NewsBenzingaIncyte ha decidido no seguir adelante con el estudio MAESTRA-3 de fase 3 previsto para evaluar INCB123667; la compañía no espera que esta determinación afecte a sus previsiones financieras ni a sus perspectivas a largo plazo previamente divulgadas. Incyte ha decidido no seguir adelante con el estudio MAESTRA-3 de fase 3 previsto para evaluar INCB123667; la compañía no espera que esta determinación afecte a sus previsiones financieras ni a sus perspectivas a largo plazo previamente divulgadas. Benzinga 2026.11.13 21:15 (GMT+0) Open on Benzinga Other news Icahn Carl Sold Holding In Jetblue Airways Corp Broadway Financial Q3 EPS $0.04 Up From $(2.86) YoY, Sales $10.392M Up From $9.039M YoY Boston Omaha Q3 EPS $(0.01) Up From $(0.08) YoY, Sales $22.178M Down From $28.734M YoY Nvidia Loses Its Founder, AMD and Broadcom Take the Crown: This Week on Wall Street Citigroup Maintains Buy on YETI Holdings, Lowers Price Target to $50 Incyte Has Decided Not To Proceed With The Planned Phase 3 MAESTRA-3 Study Evaluating INCB123667; Company Does Not Expect This Determination To Affect Its Financial Guidance Or Its Previously Disclosed Long-term Outlook
Incyte Has Decided Not To Proceed With The Planned Phase 3 MAESTRA-3 Study Evaluating INCB123667; Company Does Not Expect This Determination To Affect Its Financial Guidance Or Its Previously Disclosed Long-term Outlook
